These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 2086822

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
    Takashima T, Tsuda S, Misawa S, Horiike S, Kuzuyama Y, Hirakawa K, Nakai H, Seriu T, Tanaka S, Nishida K.
    Jpn J Antibiot; 1993 Mar; 46(3):251-8. PubMed ID: 8510322
    [Abstract] [Full Text] [Related]

  • 7. [Combination therapy with aztreonam and clindamycin on severe infections accompanying neutropenic patients with hematological disorders].
    Urabe A, Takaku F, Mizoguchi H, Nomura T, Aoki N, Yamaguchi H, Mutoh Y, Miura Y, Toyama K, Hirashima K.
    Jpn J Antibiot; 1990 Oct; 43(10):1713-22. PubMed ID: 2086813
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
    Fukuda M, Hirashima K.
    Jpn J Antibiot; 1993 Oct; 46(10):912-7. PubMed ID: 8254893
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of severe infection in patients with hematological disorders by cefminox. Tokai Infection Study Group].
    Okumura M, Ohno R, Mitomo Y, Hirano M, Shirakawa S, Yoshikawa S, Kobayashi M, Yamada K.
    Jpn J Antibiot; 1985 Jun; 38(6):1619-24. PubMed ID: 3930807
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical evaluation of a combination therapy using cefmenoxime and cefsulodin on infections complicated by hematological disorders. Tohkai Research Group on Infections in Hematopoietic Disorders].
    Minami N, Uno N, Shirakawa S, Ohno R, Okumura M, Yamamoto M, Mitomo Y, Hirano M, Shimizu S, Yamada K.
    Jpn J Antibiot; 1986 Mar; 39(3):713-20. PubMed ID: 3488423
    [Abstract] [Full Text] [Related]

  • 16. [Clinical effects of a combination treatment with cefodizime and minocycline for infections in patients complicated with hematological disorders].
    Hirakawa K, Tsuda S, Misawa S, Kuzuyama Y, Nakai H, Seriu T, Takashima T, Tanaka S, Nishigaki H, Yokota S.
    Jpn J Antibiot; 1993 Aug; 46(8):686-96. PubMed ID: 8230736
    [Abstract] [Full Text] [Related]

  • 17. [Clinical evaluation of aztreonam for infections accompanying febrile neutropenic children with hematologic disorders and solid tumors. A cooperative study].
    Hirotsu T, Akatsuka J, Hoshi Y, Uchiyama H, Fujisawa K, Kobayashi N, Ishidoya N, Ohira M, Takayama J, Ishida Y.
    Jpn J Antibiot; 1990 Dec; 43(12):2069-77. PubMed ID: 2086821
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical effects of cefodizime in severe infections complicated with hematological diseases. Hanshin Infection Study Group].
    Teshima H, Masaoka T, Hiraoka A, Horiuchi A, Hasegawa H, Kitani T, Tagawa S, Yonezawa T, Kanayama Y, Take H.
    Jpn J Antibiot; 1992 Oct; 45(10):1295-304. PubMed ID: 1479681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.